Novacyt Group, an international specialist in cancer and infectious diseases, has diversified sales from diagnostic products used in LBC, oncology, microbiology, haematology and serology testing.

We support a large global customer base which includes hospitals to large corporates. Our proprietary technology platform NOVAPREP® is a unique next generation liquid based cytology solution focused on cancer management.

Type
Public
HQ
Vélizy Villacoublay, FR
Size (employees)
67 (est)
Novacyt is headquartered in Vélizy-Villacoublay, FR

Novacyt Office Locations

Novacyt has offices in Vélizy-Villacoublay and Milton
Vélizy-Villacoublay, FR (HQ)
13 Avenue Morane Saulnier
Milton, GB
Winship Rd

Novacyt Financials and Metrics

Novacyt Financials

EUR

Market capitalization (31-Oct-2017)

10.1 m

Closing share price (31-Oct-2017)

0.7
Novacyt's current market capitalization is €10.1 m.
Show all financial metrics

Novacyt Market Value History

Novacyt's Web-traffic and Trends

Novacyt News and Updates

City Moves for 1 December 2017 - who's switching jobs?

Today's City Moves cover health, banking and insurance. Take a look at these movers and shakers: Vectura Group Vectura Group, an industry leading device and formulation business for inhaled airways products, is pleased to announce the appointment of Juliet Thompson as an independent non-execut…

Novacyt Company Life and Culture

You may also be interested in